吉利德科学表示，其一种预防艾滋病毒的药物已获得美国批准，该药物每年只需服用两次。公司指，该药物将以Yeztugo为商品名进行销售。去年发表的两项大型国际研究显示，该药物具有强大的预防艾滋病毒感染的能力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.